IRCT2012110811389N2已完成3 期
Evaluation of therapeutic effect of Montelukast and Prednison in patients with oral lichen planus
Vice Chancellor for Research , Hamedan University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 years 至 55 years（—）
- 性别
- All
入选标准
- •Inclusion criteria : (1) Diagnosis of OLP will be carried out by clinical history , physical exams and histopathological findings. (2) All of the patients should not use medication for at least two months. (3) They should not have systemic diseases such as diabetes mellitus, hepatitis and trauma history. Exclusion criteria : Patient is non-compliant with treatment until end of study.
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
The effect of Montelukast in the treatment of cystitisCystitisCystitis.IRCT20220203053919N1Arak University of Medical Sciences56
已完成
3 期
Evaluation of montelukast efficacy on clinical and FEV1/PEFR improvement in acute basthma attackAcute attack asthma.AsthmaIRCT2015092215446N5Vice chanceller for research, Ahvaz Jundishapur University of Medical Sciences80
进行中（未招募）
1 期
Efficacy and safety of Montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19)EUCTR2020-001747-21-PTInstituto de Saúde Pública Universidade Porto160
招募中
3 期
The effect of Montelukast on COVID 19 disease activityIRCT20181208041886N3Abidi Pharmaceutical company60
招募中
4 期
The effect of Monteluca on the symptoms of pyelonephritis in childreIRCT20190303042893N1Arak University of Medical Sciences100